USFDA inspects Alembic’s pharma facility in Gujarat
HT Team October 18, 2022: The USFDA has inspected India’s Alembic Pharmaceuticals’ Oncology Injectable Formulation Facility at Panelav, Gujarat, according to a BSE
Pharma
Drugs
Pharma
Gavi, Moderna sign pact for Covid-19 vaccines
HQ Team October 18, 2022: Gavi, a public-private partnership Vaccine Alliance, has signed a new pact with Moderna to supply Covid-19 vaccines to low-income countries.
Health
Medical
Prefer older people for liver transplant: Study
HT team October 17, 2022: If you are undergoing a liver transplant, will you choose a donor younger than you or older? The
Drugs
Pharma
Biocon signs out-licencing pact with Yoshindo
HQ Team October 17, 2022: Biocon Biologics, a subsidiary of India’s Biocon, has inked an out-licencing pact with Japan’s Yoshindo Inc for selling
Climate
Health
Covid-19 battle lacked global cooperation, coordination: WHO
The global response to combat the Covid-19 crisis lacked cooperation and coordination: WHO
Pharma
Marksans Pharma to acquire Israel’s Tevapharm’s site in Goa
HQ team October 12, 2022: Marksans Pharma, a listed company, is set to acquire a manufacturing site of Tevapharm, an Indian subsidiary of
Pharma
Cipla joins WEF’s ‘Lighthouse network’ to digitally transform operations
Cipla, an Indian pharmaceutical company, has joined the World Economic Forum’s Lighthouse network to adopt advanced fourth-industrial revolution technologies to transform operations digitally.
Climate
Health
Half of global poor need urgent debt relief: UNDP
HT team October 11, 2022: More than half of the world’s poorest people, living in 54 developing economies, need urgent debt relief due
Pharma
Abu Dhabi’s Platinum Owl gets CCI nod to buy stake in Intas
HT team October 11, 2022: The Competition Commission of India, the country’s anti-trust regulator has given the nod for Platinum Owl to buy
Drugs
Pharma
Israeli firm Teva Pharmaceuticals under EC scanner
The EC has intimated Teva Pharmaceutical Industries, an Israel-based global company, of its "preliminary view" that it has breached EU antitrust rules by